Two Plasma Donor Deaths at Private Canadian Clinics Under Federal Investigation
Two individuals have died in Canada after donating plasma at a chain of private clinics, which is currently under federal scrutiny for multiple safety and operational failures. The deaths occurred at facilities operated by the Spanish healthcare company Grifols, raising concerns about the oversight of blood product collection in the country.
Details of the Fatal Incidents
Health Canada, the federal regulatory agency, reported receiving notifications of "fatal adverse reactions" following plasma donations in October 2025 and January 2026. The donors experienced distress during the donation process, according to sources familiar with the cases. While the identities were not officially disclosed, friends identified one victim as Rodiyat Alabede, a 22-year-old international student who donated in Winnipeg on October 25, 2025.
"Rody aspired to become a social worker, dedicating her life to helping others, a dream she was so close to achieving," friends wrote on a GoFundMe page. "She was known for her kindness, compassion, and unwavering faith." A second death occurred three months later at another Winnipeg location, intensifying alarm among health advocates.
Regulatory Failures and Company Response
Federal inspection reports reveal significant deficiencies at Grifols clinics. In Saskatchewan, a site was rated non-compliant in January due to 11 violations, including inaccurate donor assessments and insufficient equipment maintenance. An Alberta facility had 10 similar failures. Grifols stated that a non-compliant rating indicates processes need improvement and that they are implementing corrective actions.
Grifols emphasized, "We have no reason to believe there is a correlation between the donors' passing and plasma donation." The company noted that donors undergo extensive health evaluations and that they operate under strict procedures. However, an anonymous Health Canada inspector described the non-compliance reports as "very troubling," suggesting deeper systemic issues.
Historical Context and Broader Concerns
These incidents occur against the backdrop of Canada's tainted blood scandal in the 1980s and 1990s, where contaminated products infected thousands with HIV/AIDS and hepatitis C. A royal commission later recommended a voluntary, non-commercial system for blood safety. Currently, Canada relies on imports, primarily from the U.S., as it lacks self-sufficiency in plasma production.
Only Ontario, British Columbia, and Quebec ban paid plasma donations, but Grifols circumvents this in Ontario by acting as an agent for Canadian Blood Services. The company pays up to C$100 per donation, with rewards for frequent donors, raising ethical questions about commercial incentives.
Legal and Advocacy Responses
A lawsuit is pending against a Winnipeg Grifols facility, where a donor alleged a faulty machine caused permanent kidney damage. Grifols has moved to dismiss the case, citing informed consent. Curtis Brandell, a blood safety activist, expressed shock at the deaths, noting that donation procedures are typically safe. "When I learned of a second death in the same city, alarm bells started going off," he said.
Brandell warned that private involvement risks eroding public accountability and transparency, echoing fears of a repeat of past scandals. Provincial health agencies were only recently notified of the fatalities, despite the first occurring nearly six months ago, highlighting delays in communication.
Ongoing Investigations and Industry Impact
Health Canada's investigations are ongoing, with immediate visits to clinics after each fatality. Records indicated standard procedures were followed, but critics argue this may not address underlying safety gaps. The Canadian Blood Service expressed sadness over the deaths and reaffirmed its commitment to high safety standards.
As Canada grapples with balancing plasma supply needs and safety, these deaths underscore urgent calls for stricter oversight and a reevaluation of private sector roles in critical healthcare systems.
